Management of postmenopausal women who have hyperlipidemia.
Dyslipoproteinemia is prevalent in women as well as in men. In both, its consequences of premature atherosclerosis and coronary artery disease (CAD) morbidity and mortality are common. Although clinical evidence of the benefits of cholesterol lowering is less abundant in women, it is not entirely absent. As in men, cholesterol lowering in women is associated with a decline in CAD risk and regression of coronary atherosclerosis.